Novel synthetic organosulfur compounds induce apoptosis of human leukemic cells

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1367-1374

  Wong, W Wei Lynn ^a   Macdonald, Stewart ^b   Langler, Richard F ^b   Penn, Linda Z ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MOUNT ALLISON UNIVERSITY   (Canada)

Author keywords

Apoptosis; Disulfide; Leukemia; Organosulfur compounds

Indexed keywords

ANTILEUKEMIC AGENT; ORGANOSULFUR DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL KILLING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; NICK END LABELING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PLANTS, MEDICINAL; SULFONES; SULFUR COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0343526356     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Evan G and Littlewood T: A matter of life and cell death. Science 281: 1317-22, 1998.
2. Lundberg AS and Weinberg RA: Control of the cell cycle and apoptosis. Eur J Cancer 35: 531-9, 1999.
3. Cohen JJ and al-Rubeai M: Apoptosis-targeted therapies: the 'next big thing' in biotechnology? Trends Biotechnol 13: 281-3, 1995.
4. Fisher, DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-42, 1994.
5. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-28, 1992.
6. Dimitroulakos J, Nohynek D, Backway KL, Hedley DW, Yeger H, Freedman MH, Minden MD and Penn LZ: Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Blood 93: 1308-18, 1999.
7. Jogia MK, Andersen RJ, Mantus EK and Clardy J: Dysoxysulfone, a sulfur rich metabolite from the Fijian medicinal plant Dysoxylum Richii. Tetrahedron Letters 30: 4919-4920, 1989.
8. Block E, DeOrazio R and Thiruvazhi M: Simple total synthesis of biologically-active pentathiadecane natural-products, 2,4,5,7,9-pentathiadecane 2,2,9,9-tetraoxide (dysoxysulfone), from DysoxylumRichii, and 2,3,5,7,9-pentathiadecane 9,9-dioxide, the misidentified lenthionine precursor Se-3 from Shiitake mushroom (Lentinus-Edodes). J Org Chem 59: 2273-2275, 1994.
9. Wargovich MJ: Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazinc-induced colon cancer. Carcinogenesis 8: 487-9, 1987.
10. Wargovich MJ, Woods C, Eng VW, Stephens LC and Gray K: Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res 48: 6872-5, 1988.
11. Perchellet JP, Perchellet EM and Belman S: Inhibition of DMBA-induced mouse skin tumorigenesis by garlic oil and inhibition of two tumor-promotion stages by garlic and onion oils. Nutr Cancer 14: 183-93, 1990.
12. Reddy BS, Rao CV, Rivenson A and Kelloff G: Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res 53: 3493-8, 1993.
13. Block E: The organosulfur chemistry of the genus Allium - implications for the organic chemistry of sulfur. Angew Chem Int Ed Engl 31: 1135-1178, 1992.
14. Lea MA: Organosulfur compounds and cancer. Adv Exp Med Biol 401: 147-54, 1996.
15. Baerlocher FJ, Langler RF, Frederiksen MU, Geoges NM and Witherell RD: Structure-activity relationships for selected sulfur-rich antifungal compounds. Aust J Chem 52: 167-172, 1999.
16. Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Reg 22: 27-55, 1984.
17. Chou TC, (1991) in Synergism and antagonism in chemotherapy (T. C. Chou and D. C. Rideout, eds.), pp. 61-102, Academic Press, Inc., San Diego.
18. Kasugai S, Hasegawa N and Ogura H: A simple in vitro cytotoxicity test using the MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay: analysis of eugenol toxicity on dental pulp cells (RP,C-C2A). Jpn J Pharmacol 52: 95-100, 1990.
19. Coco-Martin JM, Oherink JW, van der Velden-de Groot TA and Beuvery EC: Viability measurements of hybridoma cells in suspension cultures. Cytotechnology 8: 57-64, 1992.
20. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P and Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808, 1992.
21. Chapman RS, Chresta CM, Herberg AA, Beere HM, Heer S, Whetton AD, Hickman JA and Dive C: Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells. Cytometry 20: 245-56, 1995.
22. Rice WG, Turpin JA, Schaeffer CA, Graham L, Clanton D, Buckheit RW Jr., Zaharevitz D, Summers MF, Wallqvist A and Covell DG: Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J Med Chem 39: 3606-16, 1996.
23. Sigounas G, Hooker JL, Li W, Anagnostou A and Steiner M: S-allylmercaptocysteine, a stable thioallyl compound, induces apoptosis in erythroleukemia cell lines. Nutr Cancer 28: 153-9, 1997.
24. Sigounas G, Hooker J, Anagnostou A and Steiner M: S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutr Cancer 27: 186-91, 1997.
25. Sundaram SG and Milner JA: Diallyl disulfide inhibits the proliferation of human tumor cells in culture. Biochim Biophys Acta 1315: 15-20, 1996.
26. Sundaram SG and Milner JA: Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis 17: 669-73, 1996.
27. Knowles LM and Milner JA: Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr Cancer 30: 169-74, 1998.
28. Kirkpatrick DL, Kuperus M, Dowdeswell M, Potier N, Donald LJ, Kunkel M, Berggren M, Angulo M and Powis G: Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol 55: 987-94, 1998.